The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Chugai Pharma
Overall survival of participants compared to non-participants in a randomized-controlled trial (SELECT BC): A prospective cohort study.
 
Kazutaka Narui
No Relationships to Disclose
 
Shinji Ohno
No Relationships to Disclose
 
Hirofumi Mukai
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Novartis; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Nippon Kayaku (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Yasuo Hozumi
Consulting or Advisory Role - Kowa
 
Yasuo Miyoshi
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Taiho Pharmaceutical
 
Hiroshi Yoshino
No Relationships to Disclose
 
Hiroyoshi Doihara
No Relationships to Disclose
 
Akihiko Suto
No Relationships to Disclose
 
Motoshi Tamura
No Relationships to Disclose
 
Takashi Morimoto
No Relationships to Disclose
 
Hisamitsu Zaha
No Relationships to Disclose
 
Takashi Chishima
No Relationships to Disclose
 
Reiki Nishimura
No Relationships to Disclose
 
Takashi Ishikawa
No Relationships to Disclose
 
Yukari Uemura
No Relationships to Disclose
 
Yasuo Ohashi
Stock and Other Ownership Interests - Statcom
Honoraria - Sanofi
Consulting or Advisory Role - Chugai Pharma; Eisai; Shionogi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Takeda; Yakult Honsha